Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An updated series

被引：0
|
作者：
Shih, K. K. [1 ]
Chi, D. S. [1 ]
Barakat, R. R. [1 ]
Leitao, M. M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 112卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
306
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [1] Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M., Jr.
    GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 330 - 335
  • [2] Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S104 - S104
  • [3] Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M., Jr.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 364 - 369
  • [4] Laparoscopic cytoreduction for primary advanced or recurrent ovarian, fallopian tube, and peritoneal malignancies
    Nezhat, F. R.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S60 - S61
  • [5] Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Kerliu, Lloreta
    Myruski, Samantha
    Bhatti, Afeefa
    Soni, Priyal
    Petrosius, Paulius
    Pervanas, Helen C.
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (10) : 1010 - 1015
  • [6] Role of laparoscopy in determining optimal cytoreduction in patients with ovarian, fallopian tube and primary peritoneal cancer
    Andikyan, V.
    Kim, A. J.
    Sierra, T.
    Gretz, H. F., III
    Zakashansky, K.
    Segna, R. A.
    Beddoe, A. M.
    Dottino, P.
    Mandeli, J.
    Chuang, L. T.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 103 - 103
  • [7] Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer
    Webber, Kate
    Friedlander, Michael
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 41 : 126 - 138
  • [8] EFFECTIVENESS OF ORAL ETOPOSIDE IN RECURRENT OR REFRACTORY EPITHELIAL OVARIAN CANCER, PRIMARY PERITONEAL CANCER AND FALLOPIAN TUBE CANCER
    Kongsawatvorakul, C.
    Charakorn, C.
    Chittithaworn, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 742 - 742
  • [9] Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer
    Kongsawatvorakul, Chompunoot
    Charakorn, Chuenkamon
    Chittithaworn, Suwicha
    Lertkhachonsuk, Arb-Aroon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (06) : 2331 - 2335
  • [10] Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Sabbatini, Paul
    Dupont, Jakob
    Aghajanian, Carol
    Derosa, Felicia
    Poynor, Elizabeth
    Anderson, Sybil
    Hensley, Martee
    Livingston, Phillip
    Lasonos, Alexia
    Spriggs, David
    McGuire, William
    Reinartz, Silke
    Schneider, Sally
    Grande, Cathy
    Lele, Shashikant
    Rodabaugh, Kerry
    Kepner, James
    Ferrone, Soldano
    Odunsi, Kunle
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5503 - 5510
12345